Arzeda
PrivateLast Round
Grant
Sep 8, 2025
Total Funding Raised
$56.25M
Company Overview
Arzeda operates in Healthcare & Life Sciences and is based in Seattle, Washington. Its latest recorded funding round was a Grant round in September 2025.
Arzeda is a biotechnology company that leverages AI-driven protein design to create innovative designer proteins and enzymes for industrial, food, and pharmaceutical applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Advanced Materials, Sustainable Materials
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Arzeda Comparables
Compare Arzeda with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Biomatter | 80% | |
| Evozyne | 78% | |
| Protera Biosciences | 76% |
For institutional investors. Book with your work email.
Arzeda Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 8, 2025 | ||||
| VC Round | Sep 17, 2024 | ||||
| Series B | Mar 30, 2022 | ||||
| Corporate Funding | Nov 24, 2020 | ||||
| Series A | Nov 28, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Arzeda Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bunge Ventures | Series B, VC Round |
| Fall Line Capital | VC Round |
| Sucden Ventures | VC Round |
| WRF Capital | Series A |
| Conti Ventures | Series B |
| Universal Materials Incubator | Series B, Series A |
| Lewis & Clark Partners | Series B, VC Round |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 5, 2026
Launched ViaLeaf Reb M, a revolutionary process using Nobel Prize-winning technology.
- Mar 5, 2026
Partnering on the new ViaLeaf Reb M process.
For institutional investors. Book with your work email.
Arzeda Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Arzeda's valuation, stock price, and market status.
Is Arzeda a public or private company?
Arzeda is a private company.
What is the current stock price of Arzeda?
Arzeda is a private company, so its shares have no public market price. Caplight tracks Arzeda's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Arzeda worth (valuation)?
Valuation information for Arzeda is not publicly available.
Can I buy Arzeda stock?
Arzeda shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Arzeda's last funding round?
Arzeda's most recent funding round was Grant on September 8, 2025.
Who are the main investors in Arzeda?
Key investors in Arzeda include Conti Ventures, OS Fund, Sofinnova Partners, Continental Grain Company, National Science Foundation.
Will Arzeda IPO soon?
No public IPO plans have been announced for Arzeda.
How can I track Arzeda secondary market activity?
Caplight tracks bids, offers, and trades in Arzeda's shares on secondary markets.